First Quadrant’s NovoCure NVCR Stock Holding History

First Quadrant’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-128	Closed	-$22K	–	599
2020 Q4	$22K	Buy	+128	New	+$17.5K	﹤0.01%	513
2020 Q2	–	Sell	-2,983	Closed	-$201K	–	799
2020 Q1	$201K	Buy	2,983 +2,647	+788%	+$209K	0.03%	383
2019 Q4	$28K	Sell	336 -1,288	-79%	-$104K	﹤0.01%	541
2019 Q3	$121K	Buy	+1,624	New	+$130K	0.01%	470

Other funds holding NVCR

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Quadrant's NVCR Position: Q1 2021 in Review

First Quadrant sold out of NovoCure (NVCR) in Q1 2021, closing a stake of 128 shares — an estimated $22K sold.

First Quadrant first reported a position in NVCR in Q3 2019 and held it in 4 quarters. The position peaked at $201K in Q1 2020. 327 funds tracked by Wall St. Rank hold NVCR as of Q1 2021.

First Quadrant reported no remaining NovoCure position as of Q1 2021 after selling out during the quarter.
First Quadrant sold 128 NovoCure shares in Q1 2021, an estimated $22K.
First Quadrant first reported a position in NovoCure in Q3 2019 and held it in 4 quarters.
First Quadrant's NovoCure position peaked at $201K in Q1 2020.
327 funds tracked by Wall St. Rank held NovoCure as of Q1 2021.

Based on First Quadrant's 13F filing for Q1 2021, filed 27 Apr 2021.